Trans 112.05(3)(b)4. 4. The person has evidenced any chemical abuse or dependency within the past year.

Trans 112.05(3)(b)5. 5. The person has evidenced any chemical abuse or dependency within the past 2 years, that is not controlled by treatment.

Trans 112.05(3)(bm) (bm) For purposes of determining eligibility for a passenger endorsement under par. (b) 1. to 3., the department shall not count violations committed prior to April 1, 1992.

Trans 112.05(3)(c) (c) No person may hold any classification of operator’s license if the person is diagnosed as suffering from uncontrolled chemical abuse or dependency, as assessed by a physician, APNP or approved public treatment facility.

Trans 112.05 History History: Cr. Register, April, 1991, No. 424, eff. 5-1-91; am. (3) (b) 4., r. (3) (b) 5., Register, October, 1991, No. 430, eff. 11-1-91; emerg. cr. (3) (bm), eff. 2-20-92; cr. (3) (bm), Register, June, 1992, No. 438, eff. 7-1-92; r. (2) (b), renum. (2) (c) to (e) to be (2) (b) to (d); am. (3) (b) 4., cr. (3) (b) 5., Register, June, 1996, No. 486, eff. 7-1-96; CR 06-099: am. (2) (a) 5. and (3) (c), Register June 2007 No. 618, eff. 7-1-07.

Trans 112.06 Trans 112.06 Conditions affecting cardiovascular function.

Trans 112.06(1) (1) With respect to conditions affecting cardiovascular function, the review boards when making recommendations, and the department when taking licensing action, may consider disorders including, but not limited to, the following:

Trans 112.06(1)(a) (a) Coronary artery disease, including myocardial infarction.

Trans 112.06(1)(b) (b) Congestive heart disease.

Trans 112.06(1)(c) (c) Valvular disease or replacement valves.

Trans 112.06(1)(d) (d) Congenital heart disease.

Trans 112.06(1)(e) (e) Cardiomyopathy.

Trans 112.06(1)(f) (f) Pericardial disease.

Trans 112.06(1)(g) (g) Myocarditis.

Trans 112.06(1)(h) (h) Corpulmonale.

Trans 112.06(1)(i) (i) Conduction difficulties.

Trans 112.06(1)(j) (j) Arrhythmias.

Trans 112.06(1)(k) (k) Aortic or arterial occlusion or aneurysm.

Trans 112.06(1)(L) (L) Impairment of peripheral circulation.

Trans 112.06(2) (2) The department may require a person to provide information on the person’s functional ability including, but not limited to, the following:

Trans 112.06(2)(a) (a) Hypertension.

Trans 112.06(2)(b) (b) Orthostatic hypotension.

Trans 112.06(2)(c) (c) Presence of pain and its frequency, location, duration and intensity.

Trans 112.06(2)(d) (d) Syncope or presyncopal sensations.

Trans 112.06(2)(e) (e) Procedures which correct a cardiovascular condition and which temporarily impair functional ability, including surgical procedures such as a coronary artery bypass graft.

Trans 112.06(2)(f) (f) Pacemaker function.

Trans 112.06(2)(g) (g) Implanted defibrillator function.

Trans 112.06(2)(h) (h) Results of procedures such as an electrocardiogram, stress test with thallium scan, angiography, multigated acquisition scan, echocardiogram, or electrophysiologic studies.

Trans 112.06(2)(i) (i) Cardiac drug use, including rhythm control drugs, antianginal agents, cardiac glycosides, antihypertensive medication and side effects of these medications.